Bitmine Immersion Technologies purchased $68 million worth of Ethereum, adding 27,180 ETH to bring its total holdings to nearly 5.96 million ETH, about 4.9% of all circulating Ethereum. This makes Bitmine the largest public company holder of Ethereum, aiming to reach 5% ownership soon. Chairman Tom Lee highlighted bullish factors like tokenization, AI on blockchain, and upcoming US regulations as growth drivers. Bitmine also generates revenue by staking over 5 million ETH, projecting $330 million annually, and continues weekly purchases to hit its target.
The story on Bitmine's Ethereum accumulation provides context for readers following crypto markets. For readers following cryptocurrencies, here is Pluang's market snapshot as of Sep 14, 2026 20:03 WIB: out of 50 major cryptocurrencies, 30 rose and 19 fell today. Among notable movers, AVAX (Avalanche) rose 2.72% to Rp131.688 with 42% buy orders, contrasting with XNO (Nano) which fell 2.92% to Rp5.861 and saw 92% sell orders, while SNX (Synthetix) dropped 2.74% to Rp3.733 but had 100% buy orders. Typical hold times ranged from 69 to 86 days across these assets.
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
